A small molecule shows promise in making cancer immunotherapy affordable and accessible by targeting PD-1/PD-L1 proteins. A small molecule that could be a more accessible and effective alternative to an antibody that is successfully used to treat a range of cancers has been identified and synthesized by scientists at Tel Aviv University and the University … Continue reading Small Molecule Developed That Makes Immunotherapy Available to All Cancer Patients